ArticleGut2018

FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma.

Ning Lyu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.